Follow
Sneha Dhapare
Sneha Dhapare
Pharmacologist, FDA
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
CFD guided optimization of nose-to-lung aerosol delivery in adults: effects of inhalation waveforms and synchronized aerosol delivery
R Dutta, B Spence, X Wei, S Dhapare, M Hindle, PW Longest
Pharmaceutical research 37 (10), 199, 2020
182020
Development of a high-flow nasal cannula and pharmaceutical aerosol combination device
BM Spence, W Longest, X Wei, S Dhapare, M Hindle
Journal of aerosol medicine and pulmonary drug delivery 32 (4), 224-241, 2019
152019
Sulfated dehydropolymer of caffeic acid: In vitro anti-lung cell death activity and in vivo intervention in emphysema induced by VEGF receptor blockade
TM Truong, H Li, S Dhapare, UR Desai, NF Voelkel, M Sakagami
Pulmonary pharmacology & therapeutics 45, 181-190, 2017
142017
Scientific and regulatory activities initiated by the US food and drug administration to foster approvals of generic dry powder inhalers: bioequivalence perspective
B Newman, A Babiskin, E Bielski, S Boc, S Dhapare, L Fang, K Feibus, ...
Advanced Drug Delivery Reviews 190, 114526, 2022
132022
Excipient Enhanced Growth Aerosol Surfactant Replacement Therapy in an In Vivo Rat Lung Injury Model
FJ Kamga Gninzeko, MS Valentine, CK Tho, SR Chindal, S Boc, ...
Journal of Aerosol Medicine and Pulmonary Drug Delivery 33 (6), 314-322, 2020
122020
Salvianolic acid B as an anti-emphysema agent I: in vitro stimulation of lung cell proliferation and migration, and protection against lung cell death, and in vivo lung STAT3 …
S Dhapare, M Sakagami
Pulmonary Pharmacology & Therapeutics 53, 107-115, 2018
82018
Effect of differential drying techniques on PLGA nanoparticles containing hydrophobic and hydrophilic anticancer agents
SS Dhapare, AK Dash
Therapeutic delivery 6 (1), 27-39, 2015
82015
Scientific and regulatory activities initiated by the US Food and Drug Administration to foster approvals of generic dry powder inhalers: quality perspective
N El-Gendy, CM Bertha, M Abd El-Shafy, DK Gaglani, A Babiskin, ...
Advanced Drug Delivery Reviews 189, 114519, 2022
72022
Advancements in the design and development of dry powder inhalers and potential implications for generic development
AR Mohan, Q Wang, S Dhapare, E Bielski, A Kaviratna, L Han, S Boc, ...
Pharmaceutics 14 (11), 2495, 2022
62022
Considerations for the Forced Expiratory Volume in 1 Second‐Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug Products
J Lee, K Feng, DS Conti, R Walenga, M Wientjes, H Wang, B Newman, ...
Clinical Pharmacology & Therapeutics 112 (5), 982-989, 2022
42022
Medication cost-savings and utilization of generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) drug products in the USA
Z Wang, SK Ahluwalia, B Newman, S Dhapare, L Zhao, MC Luke
Therapeutic Innovation & Regulatory Science 56 (2), 346-357, 2022
42022
Pharmacokinetic profile analyses for inhaled drugs in humans using the lung delivery and disposition model
A Raut, S Dhapare, J Venitz, M Sakagami
Biopharmaceutics & Drug Disposition 41 (1-2), 32-43, 2020
42020
Salvianolic acid B as an anti-emphysema agent II: In vivo reversal activities in two rat models of emphysema
S Dhapare, H Li, M Sakagami
Pulmonary Pharmacology & Therapeutics 53, 52-60, 2018
42018
Multifunctional nanoparticles containing hydrophilic and hydrophobic drugs for anticancer drug delivery
S Dhapare
Creighton University, 2013
12013
In Vitro Evaluation of Intersubject Variability in Pediatric Intranasal Drug Delivery Using Nasal Spray Suspension Products
AR Esmaeili, JV Wilkins, S Hosseini, A Alfaifi, M Hejazi, M Hindle, ...
Journal of Aerosol Science, 106387, 2024
2024
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays
E Amini, SM Berger, U Schilling, Y Jiao, MJ Chen, S Bachhav, ...
Molecular Pharmaceutics 20 (11), 5690-5700, 2023
2023
Combination devices, systems, and methods for humidification of the airways and high efficiency delivery of pharmaceutical aerosols
PW LONGEST, M Hindle, B Spence, S Dhapare, W Xiangyin
US Patent 11,534,569, 2022
2022
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective
ZL El-Gendy N, Bertha CM, Abd El-Shafy M, Gaglani DK, Babiskin A, Bielski E ...
Advanced Drug Delivery Reviews 189, 114519, 2022
2022
Systematic Evaluation of the Effect of Formulation Variables on In Vitro Performance of Mometasone Furoate Suspension-Metered Dose Inhalers
SS Bachhav, P Sheth, D Sandell, M Svensson, S Bhagwat, DS Conti, ...
The AAPS journal 24 (1), 9, 2021
2021
Effects of Realistic In Vitro Test Factors on the Aerosol Properties of Metered-Dose Inhalers (MDIs)
S Dhapare, A Mohan, B Newman, M Svensson, P Elfman, D Sandell, ...
Drug Delivery to the Lungs 32, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20